Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 51 results
February 2020
-
In The NewsNovartis CEO Vasant Narasimhan on building trust with societyVas Narasimhan, CEO of Novartis, and CNBC’s Meg Tirrell joins “Closing Bell” in an exclusive interview at the JPMorgan Healthcare Conference.
-
In The NewsNovartis Pharmaceuticals head on chief, Marie-France Tschudin on rethinking the drug-launch formulaTschudin talks with FiercePharma at the J.P. Morgan Healthcare Conference.about a “value-based approach” to drug launches.
April 2019
-
In The NewsHow to be a boss in an unbossed companyIn this interview, Novartis CEO Vas Narasimhan sits down with CNNMoney Switzerland’s Urs Gredig and shares why he thinks innovation should come from the bottom and how wearing jeans and no…
-
In The NewsMedicines and transformative effectIn this Bloomberg interview, Vas Narasimhan, CEO of Novartis shares his thoughts on how medicines can have a transformative effect.
January 2019
-
In The NewsFortune's Most Admired Pharmaceutical Companies 2019Novartis ranks #4 in Fortune Magazine’s Most Admired Companies Pharmaceutical Industry list.
-
In The NewsThe Science and Business of Innovative MedicinesIn this a16z podcast, bio general partners Jorge Conde and Vijay Pande with Sonal Chokshi interview Vas Narasimhan, CEO of Novartis, on some questions, challenges and opportunities that we’re facing…
September 2017
-
In The NewsNovartis Access and government of Cameroon sign agreement to fight chronic diseasesCameroon faces a serious increase in chronic diseases like heart disease, asthma, cancer and diabetes. This agreement complements the government’s ongoing efforts by improving access to affordable…
-
In The NewsChanging the worldNovartis was ranked 4th in Fortune magazine’s Change the World list and cited for developing an innovative new cancer treatment, working to expand access to healthcare and supporting value-based…